News
10-18-2018, 10:14 PM
Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy after one year of treatment, potentially putting themselves at increased risk of recurrence and reduced survival, a French prospective study reports at ESMO 2018.
More... (https://www.news-medical.net/news/20181019/High-rate-of-non-adherence-to-hormonal-therapy-found-among-premenopausal-early-breast-cancer-patients.aspx)
More... (https://www.news-medical.net/news/20181019/High-rate-of-non-adherence-to-hormonal-therapy-found-among-premenopausal-early-breast-cancer-patients.aspx)